Gainers
- MingZhu Logistics Holdings Limited YGMZ shares gained 64% to $0.7798 after gaining more than 10% on Friday.
- PCTEL, Inc. PCTI climbed 47.3% to $6.86. On Friday, Amphenol Corp APH inked a deal to acquire PCTEL for around $139.7 million.
- Almacenes Éxito S.A. EXTO shares rose 32.6% to $6.66.
- MMTec, Inc. MTC surged 30% to $0.7608.
- Tempest Therapeutics, Inc. TPST gained 29% to $4.72.
- LQR House Inc. LQR shares climbed 24.5% to $0.2148. LQR House announced that through its custom marketing campaign and strategic efforts, Von Payne Whiskey is now displayed on the shelves of the retail giant, Costco.
- Secoo Holding Limited SECO rose 23% to $0.7868 after declining 37% on Friday.
- Ensysce Biosciences, Inc. ENSC climbed 22.2% to $1.76.
- E2open Parent Holdings, Inc. ETWO gained 22% to $3.00. Elliott Investment Management L.P. reported a 9% stake in E2open Parent Holdings as of Oct. 13.
- Inotiv, Inc. NOTV climbed 21.2% to $2.4850.
- Zapp Electric Vehicles Group Limited ZAPP gained 21.2% to $0.6195.
- Processa Pharmaceuticals, Inc. PCSA shares jumped 20.8% to $0.5799 after jumping 45% on Friday.
- Mereo BioPharma Group plc MREO climbed 20% to $1.55. Ultragenyx and Mereo BioPharma announced interim Phase 2 data from Phase 2/3 Orbit study demonstrating setrusumab significantly reduced fracture rates in patients with osteogenesis imperfecta.
- Prothena Corporation plc PRTA gained 19.7% to $52.78.
- Alignment Healthcare, Inc. ALHC gained 17.8% to $7.80 after Raymond James upgraded the stock from Outperform to Strong Buy and raised its price target from $9 to $10.
- Consolidated Communications Holdings, Inc. CNSL surged 17.5% to $4.1493 after the company announced an agreement to be acquired by Searchlight Capital Partners and British Columbia Investment Management.
- Modular Medical, Inc. MODD gained 17.4% to $1.08.
- Catalyst Biosciences, Inc. CBIO rose 15.5% to $0.39.
- indie Semiconductor, Inc. INDI climbed 15% to $5.60. indie Semiconductor expects third-quarter revenue to be above $60 million, slightly higher than the company's guidance and consensus estimates.
- CNS Pharmaceuticals, Inc. CNSP gained 14.2% to $1.5527.
- RedHill Biopharma Ltd. RDHL shares rose 13.8% to $0.3639 after falling 14% on Friday.
- Cardlytics, Inc. CDLX climbed 11.9% to $12.35.
- MoonLake Immunotherapeutics MLTX gained 11.5% to $60.98 after the company announced 24-week top-line results from its global Phase 2 MIRA trial for maintenance treatment with its Nanobody sonelokimab.
- NanoVibronix, Inc. NAOV surged 11.5% to $1.2828.
- ATRenew Inc. RERE climbed 11.3% to $1.78.
- Momentus Inc. MNTS shares gained 10.8% to $3.4450.
- Overstock.com, Inc. OSTK climbed 10.5% to $16.61. Overstock.com 13D filing showed JAT Capital Mgmt LP reported a 9.1% stake in the company as of Oct. 12.
- Lululemon Athletica Inc. LULU surged 9.8% to $414.67 after it was announced the stock will join the S&P 500.
- ESSA Pharma Inc. EPIX gained 8.4% to $2.9696.
- Snap Inc. SNAP climbed 8.4% to $9.40.
Losers
- Streamline Health Solutions, Inc. STRM shares dipped 68.2% to $0.2350 after the company announced it is undergoing a strategic restructuring to cut expenses.
- Aldeyra Therapeutics, Inc. ALDX shares fell 66.7% to $1.81. The company received feedback from the U.S. Food and Drug Administration (FDA) regarding their new drug application (NDA) for reproxalap, intended for treating dry eye disease.
- Biocept, Inc. BIOC fell 46% to $0.5503. Biocept said Antonino Morales tendered his resignation as the company's President And Chief Executive Officer, effective on Oct. 13, 2023. The company also filed voluntary petition under the provisions of Chapter 7 in Bankruptcy Court.
- Omeros Corporation OMER dropped 37.4% to $1.42 after the company announced it will discontinue the ARTEMIS-IGAN trial, which did not reach statistical significance on the primary endpoint of reduction in proteinuria from baseline compared to placebo.
- Ambrx Biopharma Inc. AMAM fell 36.2% to $8.97. Ambrx Biopharma said that two abstracts detailing updated safety and efficacy data from the ongoing Phase 1/2 trial, APEX-01 of ARX517 for metastatic castration-resistant prostate cancer were made available at the European Society of Medical Oncology.
- The NFT Gaming Company, Inc. NFTG declined 35.3% to $0.6255.
- Sigma Additive Solutions, Inc. SASI fell 32.8% to $3.99 after jumping 140% on Friday.
- Shift Technologies, Inc. SFT shares fell 30.3% to $0.11. Maruthi J. D. Venkata reported a 4.8% stake in Shift Technologies as of Oct 12, 2023 versus an 11.5% stake reported as of March 14, 2023.
- Vista Outdoor Inc. VSTO declined 24.6% to $24.72 after the company lowered FY24 guidance and announced it entered into a definitive agreement to sell its sporting products business.
- RVL Pharmaceuticals plc RVLP declined 23% to $0.0557. RVL Pharmaceuticals said on Oct. 12, that the company received delisting notice from Listing Qualifications Department of Nasdaq Stock Market LLC.
- Nexalin Technology, Inc. NXL fell 22% to $0.3664. Nexalin Technology announced publication of groundbreaking deep-brain stimulation study in leading peer-reviewed journal.
- Elys Game Technology, Corp. ELYS declined 21.4% to $0.4050.
- ShiftPixy, Inc. PIXY fell 20.6% to $13.60.
- Versus Systems Inc. VS fell 16.5% to $0.1956. Versus Systems reported pricing of $3.0 million public offering.
- Nxu, Inc. NXU fell 15.5% to $0.0769.
- MoneyHero Limited MNY declined 15.5% to $2.83.
- UTime Limited WTO shares fell 12.7% to $0.2750, after gaining over 7% on Friday.
- FaZe Holdings Inc. FAZE shares fell 11.8% to $0.2056 after jumping around 25% on Friday.
- Tango Therapeutics, Inc. TNGX declined 11.5% to $6.80.
- Clover Health Investments, Corp. CLOV declined 10.8% to $0.9181.
- Procaps Group S.A. PROC fell 9.7% to $2.5444.
- Manchester United plc MANU shares fell 9.5% to $18.08 after a Qatari investor group led by Sheikh Jassim Bin Hamad J.J. Al Thani reportedly withdrew its bid to acquire the club.
- Bio-Path Holdings, Inc. BPTH shares fell 9.3% to $0.6804 after jumping around 111% on Friday.
- Novavax, Inc. NVAX declined 7.9% to $6.49. Shares of vaccine stocks traded lower after Pfizer reduced its 2023 COVID vaccine revenue outlook.
- ParaZero Technologies Ltd. PRZO shares fell 7.6% to $3.05, after jumping 55% on Friday.
- GameStop Corp. GME declined 4.7% to $14.22. GameStop General Counsel and Secretary Haymond Mark Robinson sold a total of 11,966 shares at an average price of $15.48.
- BioNTech SE BNTX fell 4.1% to $99.34 after the company's partner, Pfizer, cut its COVID-19 vaccine and therapy sales outlook.
Now Read This: Tesla Options Trading Surges Ahead Of Wednesday Earnings Report
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in